Product
Advertisement
CD2-CD58 Axis: Targets in Immune Synapse
Recent studies have highlighted the CD2-CD58 axis's relevance in cancer immunotherapy, suggesting its potential to enhance anti-tumor immunity and making it a promising target for therapeutic interventions. The CD2-CD58 axis is associated with the regulation of autoimmune diseases, immune evasion of tumors, antiviral responses, and immune rejection, and targeted therapies for this have been developed.
Sino Biological offers a wide range of recombinant CD2 and CD58 proteins and antibodies to support elucidating key interactions and pathways and shedding light on potential therapeutic strategies.
About Sino Biological
Sino Biological, an international reagent supplier and service provider, specializes in recombinant protein production and antibody development. All of the products are independently developed and produced, including recombinant proteins, antibodies and cDNA. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements and offers pre-clinical production technology services for monoclonal antibody drug candidates.
Interested in seeing more content from Sino Biological?
Discover all their latest news, webinars, products and more by clicking the link below.
